2010
Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies
Search citation statements
Paper Sections
Select...
80
15
3
2
Citation Types
1
44
0
0
Year Published
2011
2025
Publication Types
Select...
86
6
3
1
Relationship
3
93
Authors
Journals
Cited by 96 publications
(45 citation statements)
References 44 publications
1
44
0
0
“…Interesting result obtained from monitoring blood glucose level after intranasal administration showed similar glucose lowering ability for both test formulations and standard subcutaneously administered insulin. This is similar to previously reported results by Sintov et al [18] and Forst et al [19]. This shows that this formulation can release therapeutically sufficient quantities of insulin to achieve normoglycemia.…”
Section: Time (H)supporting
confidence: 92%
“…Interesting result obtained from monitoring blood glucose level after intranasal administration showed similar glucose lowering ability for both test formulations and standard subcutaneously administered insulin. This is similar to previously reported results by Sintov et al [18] and Forst et al [19]. This shows that this formulation can release therapeutically sufficient quantities of insulin to achieve normoglycemia.…”
Section: Time (H)supporting
confidence: 92%
“…The average droplet size of drugunloaded microemulsion containing 20% water (surfactants-to-oil ratio = 87:13) was 2 nm in diameter (99.7% of total droplets). Our previous studies using this microemulsion system showed that loading of drug molecules and even of protein drugs into the nano-droplets did not much change the average droplet size [25].…”
Section: Resultsmentioning
confidence: 83%
“…This approach enables controlled drug release, faster absorption, and a less invasive alternative that enhances patient adherence. Intranasal delivery also offers additional advantages, such as reduced discomfort compared to subcutaneous injections and the potential to bypass hepatic metabolism, favoring a more rapid and direct effect on glycemic control [ 87 , 88 , 89 , 90 , 91 ]. Therefore, intranasal insulin nano- and microemulsions represent a significant advancement in diabetes therapy by combining efficacy, convenience, and improved patient comfort.…”
Section: Resultsmentioning
confidence: 99%
